Myriad Genetics, Inc. (NASDAQ:MYGN) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have received a consensus recommendation of “Hold” from the sixteen research firms that are covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, ten have assigned a hold recommendation and four have given a buy recommendation […]
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have received a consensus recommendation of “Hold” from the sixteen research firms that are covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, ten have assigned a hold recommendation and four have given a buy recommendation […]
